Clinical trials recruiting for Drug Resistance
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Low-dose radiotherapy to the intestine (ILDR) | 1 |
| PD-1/PD-L1 monoclonal antibodies | 1 |
Self-screener
Recruiting trials
- Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
- Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
Related conditions
Trials recruiting for Drug Resistance often also study these conditions. Each links to its own recruiting-trial list.
Triple-Negative Breast Cancer (TNBC) 35Radiotherapy 31Metastatic breast cancer 131Lung Neoplasm Malignant 8Lung cancer 2180Hormone Receptor-Positive Breast Cancer 24HER2-positive breast cancer 75Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Drug Resistance trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.